We are live on ! Find out more
TS

Thomas Steyer Farallon Capital Management

AUM $21.7B
1-Year Est. Return 79.24%
 

Thomas Steyer founded Farallon Capital Management, a pioneering multi-strategy firm spanning credit, equities, real estate, and event-driven investing. Farallon became known for rigorous research and opportunistic capital allocation across cycles. Although Steyer later focused on public advocacy, the Farallon name remains important in hedge fund history and ongoing 13F tracking.

This Fund
S&P 500
This Quarter Est. Return
+3.56%
1 Year Est. Return
+79.24%
3 Year Est. Return
+204.51%
5 Year Est. Return
+270.91%
10 Year Est. Return
+1,884.18%
AUM
$14.4B
AUM Growth
+$2.13B
Cap. Flow
+$2.21B
Cap. Flow %
15.31%
Top 10 Hldgs %
53.56%
Holding
108
New
27
Increased
43
Reduced
13
Closed
22

Top Buys

Rank Stock Value
1
COL
Rockwell Collins
COL
+$391M
2
MON
Monsanto Co
MON
+$386M
3
KDP icon
Keurig Dr Pepper
KDP
+$362M
4
LOGM
LogMein, Inc.
LOGM
+$212M
5
TFCF
Twenty-First Century Fox, Inc. Class B
TFCF
+$182M

Top Sells

Rank Stock Value
1
TWX
Time Warner Inc
TWX
+$306M
2
AABA
Altaba Inc
AABA
+$248M
3
BUD icon
AB InBev
BUD
+$164M
4
CPN
Calpine Corporation
CPN
+$163M
5
HUN icon
Huntsman Corp
HUN
+$80.7M

Sector Composition

Rank Sector Weight
1 Technology 21.51%
2 Healthcare 15.68%
3 Communication Services 13.68%
4 Financials 11.37%
5 Industrials 10.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ARRY
51
DELISTED
Array Biopharma Inc
ARRY
$50.5M 0.35%
+3,095,000
New +$49.6M
XPO icon
52
XPO
XPO
$23.2B
$48.4M 0.33%
1,373,412
+1,113,187
+428% +$37.1M
ALNY icon
53
Alnylam Pharmaceuticals
ALNY
$31.6B
$44.1M 0.31%
+370,000
New +$47.7M
VEON icon
54
VEON
VEON
$4.09B
$40.9M 0.28%
620,040
-557,301
-47% -$46.7M
NVCR icon
55
NovoCure
NVCR
$1.99B
$40.3M 0.28%
1,850,000
+685,000
+59% +$14.7M
AVXS
56
DELISTED
AveXis, Inc. Common Stock
AVXS
$36.3M 0.25%
+294,000
New +$34.9M
RC
57
Ready Capital
RC
$311M
$33.5M 0.23%
2,208,239
+8,232
+0.4% +$120K
LKFT
58
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.89B
$30.8M 0.21%
308,260
+18,260
+6% +$1.97M
CI icon
59
Cigna
CI
$73.3B
$30.2M 0.21%
+180,000
New +$35M
CRSP icon
60
CRISPR Therapeutics
CRSP
$5.75B
$29.5M 0.2%
645,000
-213,602
-25% -$8.82M
BMS
61
DELISTED
Bemis
BMS
$24.5M 0.17%
562,500
+502,500
+838% +$22.9M
AVA icon
62
Avista
AVA
$3.15B
$20.5M 0.14%
+400,000
New +$20.2M
SVRA icon
63
Savara
SVRA
$1.15B
$20.5M 0.14%
2,225,000
– –
HAIN icon
64
Hain Celestial
HAIN
$71.6M
$17.5M 0.12%
545,000
+255,000
+88% +$9.26M
VYGR icon
65
Voyager Therapeutics
VYGR
$209M
$16.7M 0.12%
890,000
+235,188
+36% +$5.08M
EVHC
66
DELISTED
Envision Healthcare Holdings Inc
EVHC
$14M 0.1%
+365,000
New +$13.6M
AMRN
67
Amarin Corp
AMRN
$298M
$13.7M 0.1%
+228,000
New +$16.9M
NTLA icon
68
Intellia Therapeutics
NTLA
$1.8B
$13.7M 0.09%
650,000
-490,000
-43% -$12.1M
ZEAL
69
DELISTED
Zealand Pharma A/S American Depositary Shares
ZEAL
$13M 0.09%
865,000
+215,000
+33% +$3.34M
CCXI
70
DELISTED
ChemoCentryx, Inc.
CCXI
$12.9M 0.09%
+950,000
New +$9.8M
TROX icon
71
Tronox
TROX
$888M
$12.7M 0.09%
688,006
+498,631
+263% +$9.93M
BOLD
72
DELISTED
Audentes Therapeutics, Inc
BOLD
$9.62M 0.07%
320,000
+338
+0.1% +$11.4K
CBI
73
DELISTED
Chicago Bridge & Iron Nv
CBI
$9.5M 0.07%
+660,000
New +$12.1M
VOYA icon
74
Voya Financial
VOYA
$8.86B
$9.34M 0.06%
+185,000
New +$9.55M
SYBX
75
DELISTED
Synlogic
SYBX
$9.15M 0.06%
+65,000
New +$10.1M
1 2
3
4 5

Similar funds

BG
Bahl & Gaynor Cincinnati, Ohio $21.7B AUM 30.58% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.7B AUM 77.3% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $21.7B AUM 41.93% 1-Year Est. Return
SA
Sanctuary Advisors Indianapolis, Indiana $21.6B AUM 28.31% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $21.5B AUM 23.65% 1-Year Est. Return
CHP
Castle Hook Partners New York $21.8B AUM 215.45% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Thomas Steyer's Q1 2018 Portfolio in Review

As of Q1 2018, Thomas Steyer held 108 positions worth $14.4B, up 17% from $12.3B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Thomas Steyer deployed $2.21B of net new capital in Q1 2018, opening 27 new positions and adding to 43 existing holdings. Its largest new stake was Keurig Dr Pepper: 3,265,800 shares worth $387M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 22% a quarter earlier, followed by Healthcare and Communication Services.

On the sell side, the largest reduction was Time Warner Inc, an estimated $306M trimmed.

  • Thomas Steyer's largest Q1 2018 buy was Keurig Dr Pepper: 3,265,800 shares worth $387M.
  • Thomas Steyer added most to Rockwell Collins in Q1 2018, an estimated $391M increase.
  • Thomas Steyer's biggest Q1 2018 reduction was Time Warner Inc, cutting an estimated $306M.
  • Thomas Steyer fully exited AB InBev in Q1 2018, selling an estimated $164M.
  • Thomas Steyer's ten largest holdings make up 54% of its $14.4B portfolio in Q1 2018.
  • Thomas Steyer opened 27 new positions and closed 22 in Q1 2018.
  • Thomas Steyer's portfolio value rose 17% quarter-over-quarter to $14.4B.

Based on Farallon Capital Management's 13F filing for Q1 2018, filed 15 May 2018.